A prospective observational study on host immunity for development of novel immunotherapeutic strategy for treatment and prevention of postoperative infections
Not Applicable
Recruiting
- Conditions
- - Respiratory, digestive, and cardiovascular diseases scheduled for surgery - Postoperative infections
- Registration Number
- JPRN-UMIN000050678
- Lead Sponsor
- agoya University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 75
Inclusion Criteria
Not provided
Exclusion Criteria
-Patients within 1 months of recovery from an acute infection -Patients with chronic hepatic disorders due to HBV or HCV infections. -HIV-positive patients -Patients previously treated with chemotherapy, immune checkpoint inhibitors, or radiation therapy for malignant tumors. -Patients with active multiple cancers. -Patients with active hematologic malignancies. -Patients with hemoglobin level <= 10 g/dL. -Patients after blood stem cell transplants, including bone marrow transplants. -Patients treated for co-morbidities with high-dose glucocorticoid, immunosuppressive drugs, or biological agents. -Elderly patients who are 90 years old or older. -Pregnant women.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method